Kayla Milano
Family Medicine · Hermitage, PANPI 1780116806
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $808 and has fallen 87.2% since, to $103 in 2025.
Across 66 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$196
- Pfizer$158
- AbbVie$131
- Amarin Pharma, Inc.$108
- Lilly USA, LLC$101
- GSK$96
- plus $369 from 14 others
What the payments were for
- Food & beverage$1,159100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $196 |
| Pfizer | 10 | $158 |
| AbbVie | 7 | $131 |
| Amarin Pharma, Inc. | 6 | $108 |
| Lilly USA, LLC | 6 | $101 |
| GSK | 6 | $96 |
| Boehringer Ingelheim | 3 | $53 |
| Galderma Laboratories, L.p. | 3 | $46 |
| Fidia Pharma USA Inc. | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| AstraZeneca | 2 | $29 |
| Merck | 1 | $24 |
| Abbott | 1 | $24 |
| Nevro Corp. | 1 | $23 |
| Boston Scientific | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $17 |
| Novartis | 1 | $17 |
| Johnson & Johnson | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $10 |
How this compares
$1,159 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 13 | $137 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Hermitage
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.